Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
National Institutes of Health Clinical Center (CC)
Pfizer
Eastern Cooperative Oncology Group
Pfizer
University of Nebraska
Adela, Inc
The University of Texas Health Science Center at San Antonio
Jonsson Comprehensive Cancer Center
Azienda Ospedaliera di Padova
Apollomics Inc.
Columbia University
Algemeen Ziekenhuis Maria Middelares
Children's Hospitals and Clinics of Minnesota